Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors

被引:52
作者
Baytas, Sultan Nacak [1 ]
Inceler, Nazan [1 ]
Yilmaz, Akin [2 ]
Olgac, Abdurrahman [1 ]
Menevse, Sevda [2 ]
Banoglu, Erden [1 ]
Hamel, Ernest [3 ]
Bortolozzi, Roberta [4 ]
Viola, Giampietro [4 ]
机构
[1] Gazi Univ, Div Pharmaceut Sci, Dept Pharmaceut Chem, Fac Pharm, TR-06330 Ankara, Turkey
[2] Gazi Univ, Dept Med Biol & Genet, Fac Med, TR-06500 Ankara, Turkey
[3] NCI, Screening Technol Branch, Dev Therapeut Program,NIH, Div Canc Treatment & Diag,Frederick Natl Lab Canc, Frederick, MD 21702 USA
[4] Univ Padua, Dept Womens & Childrens Hlth, Lab Oncohematol, I-35128 Padua, Italy
关键词
Synthesis; Anticancer activity; Indole; Tubulin polymerization; Colchicine binding; Apoptosis; Cell cycle arrest; Molecular docking; RAPID COLORIMETRIC ASSAY; ANTIMITOTIC AGENTS; CHALCONES; ANALOGS; COLCHICINE; GROWTH; CHEMISTRY; SURVIVAL; DESIGN; CELLS;
D O I
10.1016/j.bmc.2014.04.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we synthesized a series of trans-indole-3-acrylamide derivatives (3a-k) and investigated their activity for inhibition of cell proliferation against five human cancer cell lines (HeLa, MCF7, MDA-MB-231, Raji and HL-60) by MTT assay. Compound 3e showed significant antiproliferative activity against both the Raji and HL-60 cell lines with IC50 values of 9.5 and 5.1 mu M, respectively. Compound 3e also exhibited moderate inhibitory activity on tubulin polymerization (IC50 = 17 mu M). Flow cytometric analysis of cultured cells treated with 3e also demonstrated that the compound caused cell cycle arrest at the G2/M phase in HL-60 and HeLa cells. Moreover, 3e, the most active compound, caused an apoptotic cell death through the activation of caspase-3. Docking simulations suggested that 3e binds to the colchicine site of tubulin. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3096 / 3104
页数:9
相关论文
共 47 条
  • [1] Synthesis of substituted indole derivatives as a new class of antimalarial agents
    Agarwal, A
    Srivastava, K
    Puri, SK
    Chauhan, PMS
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) : 3133 - 3136
  • [2] Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones
    Aponte, Jose C.
    Verastegui, Manuela
    Malaga, Edith
    Zimic, Mirko
    Quiliano, Miguel
    Vaisberg, Abraham J.
    Gilman, Robert H.
    Hammond, Gerald B.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (19) : 6230 - 6234
  • [3] Antimitotic and antiproliferative activities of chalcones: Forward structure-activity relationship
    Boumendjel, Ahcene
    Boccard, Juien
    Carrupt, Pierre-Alain
    Nicolle, Edwige
    Blanc, Madeleine
    Geze, Annabelle
    Choisnard, Luc
    Wouessidjewe, Denis
    Matera, Eva-Laure
    Dumontet, Charles
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (07) : 2307 - 2310
  • [4] Synthetic chalcones, flavanones, and flavones as antitumoral agents:: Biological evaluation and structure-activity relationships
    Cabrera, Mauricio
    Simoens, Macarena
    Falchi, Gabriela
    Lavaggi, M. Laura
    Piro, Oscar E.
    Castellano, Eduardo E.
    Vidal, Anabel
    Azqueta, Amaia
    Monge, Antonio
    de Cerain, Adela Lopez
    Sagrera, Gabriel
    Scoane, Gustavo
    Cerecetto, Hugo
    Gonzalez, Mercedes
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (10) : 3356 - 3367
  • [5] Calliste CA, 2001, ANTICANCER RES, V21, P3949
  • [6] Cozzi Paolo, 2003, Farmaco (Lausanne), V58, P213, DOI 10.1016/S0014-827X(03)00014-4
  • [7] RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY
    DENIZOT, F
    LANG, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) : 271 - 277
  • [8] Dhar D.N., 1981, CHEM CHALCONES RELAT
  • [9] Dimmock JR, 1999, CURR MED CHEM, V6, P1125
  • [10] Chalcones: An update on cytotoxic and chemoprotective properties
    Go, ML
    Wu, X
    Liu, XL
    [J]. CURRENT MEDICINAL CHEMISTRY, 2005, 12 (04) : 483 - 499